LAVA Therapeutics N.V.

NASDAQ:LVTX

1.82 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q32019 Q22019 Q1
Operating Activities:
Net Income -8.296-0.484-6.437-8.786-12.603-13.869-14.9291.044-7.277-10.496-12.13-9.216-8.478-22.824-5.309-5.046-4.484-4.411-2.373-2.463-2.436
Depreciation & Amortization 0.2280.2470.3520.3180.2950.3130.2710.1680.1740.1680.3750.1840.0010.080.4120.0790.0580.0430.0640.0660.065
Deferred Income Tax -0.085-0.069-0.06-0.051-0.097-0.071-0.068-0.046-0.075-0.06-0.066-0.05-0.037-0.029-0.0530.2130.004-0.004000
Stock Based Compensation 0.8211.0950.9250.9241.561.630.9060.8410.3782.2331.6221.4011.2170.7450.2830.0880.1280.1820.0470.0490.049
Change In Working Capital -0.13-0.581-6.0521.598-1.5593.18645.984-13.6710.9140.8862.767-1.409-5.44916.706-5.1990.0138.4761.4690.1520.1570.156
Accounts Receivables -0.2560.693-0.582.676-1.8021.28746.862-53.349-0.10100-1.1640.0360.761-1.233-0.0030.148-0.2080.0090.0090.009
Change In Inventory 000.58-2.6761.802-1.287-43.42153.3490.101001.22-5.25616.778-1.1320.161-0.0130.019000
Change In Accounts Payables 0.762-0.915-5.1144.4161.948-0.916-3.444.8690.1330.1050.671-0.2741.0570.437-1.4170.601-0.9181.896000
Other Working Capital -0.636-0.424-0.938-5.494-3.5074.10245.984-18.540.7810.7812.096-1.191-1.286-1.27-1.417-0.7459.259-0.2390.1420.1480.146
Other Non Cash Items -0.1970.5121.152-1.455-0.6610.4763.571-2.62-3.649-0.3590.5010.0740.2340.358-0.1440.1140.4070.044000
Operating Cash Flow -8.346-1.125-10.12-7.452-13.065-8.33535.735-14.344-9.72-7.628-6.931-9.016-12.512-4.964-10.01-4.544.589-2.675-2.11-2.19-2.166
Investing Activities:
Investments In Property Plant And Equipment 000.009-0.006-0.224-0.5-0.2650.025-0.024-0.323-0.209-0.5680.072-0.189-0.115-0.332-0.031-0.145-0.198-0.206-0.203
Acquisitions Net 0.0030.089015.932-0.41103.618-6.692-3.393000000000000
Purchases Of Investments -31.44-24.371-36.187-29.343-24.5520-24.329-7.937-21.37-17.241-3.6230000000000
Sales Maturities Of Investments 31.7722527.512.5258.17720.45514.49524.92520.93500000000000
Other Investing Activites 0.3390-0.009-15.9320.4117.538-3.6186.6923.39302.846-48.860.011000.001-0-0.001-0.007-0.007-0.007
Investing Cash Flow 0.3350.718-8.687-16.8490.2247.677-4.1396.5833.5313.371-0.986-49.4280.083-0.189-0.115-0.331-0.031-0.146-0.205-0.213-0.211
Financing Activities:
Debt Repayment -0.128-0.008-0.305-0.247-0.275-0.214-0.118-0.106-0.083-0.03600-0.026-0.007-0.168-0.018-0.072-0.044-0.024-0.024-0.024
Common Stock Issued 0.0170.00800000000-0.05-2.840.843112.8780000000
Common Stock Repurchased 00000000000.2030.161-0.098-6.354-0.28-5.62300000
Dividends Paid 000000000000-1.919-71.490000000
Other Financing Activities 0.01700.1250.110.1180.1170.1020.0990.1190.3061.359-1.2018.615137.7771.53226.7530.5820.4920.310.3220.318
Financing Cash Flow 0.0050-0.18-0.137-0.157-0.097-0.016-0.0070.0360.271.512-3.887.414172.8051.08421.1130.510.4480.2870.2970.294
Other Information:
Effect Of Forex Changes On Cash -0.061-0.6370.555-0.5060.0011.0264.421-3.767-3.703-1.159-5.3491.972-1.4460.378-0.358-0.466-0.3390.222000
Net Change In Cash -8.101-1.044-18.432-24.944-12.9970.27136.001-11.535-9.856-5.146-10.76-60.802-6.189168.03-8.9516.1554.889-2.374-2.029-2.105-2.083
Cash At End Of Period 35.08643.18744.23162.66387.607100.604100.33364.33275.86785.723103.019116.486181.222185.79119.42927.16910.5565.481.791.8581.837